We found that, following DDP treatment, silencing of XIAP reversed the improvement of CAFs-oe-EVs on IC50 values in NSCLC cells, the promotive effect of CAFs-oe-EVs on cell proliferation, and the inhibitory effect of CAFs-oe-EVs on cell apoptosis. The gene discussed is XIAP; the disease is non-small cell lung carcinoma.